All Reports Events Blogs Videos
Showing 82 results
  • NEW
    Blog
    Aug. 06, 2026

    Dassault Systèmes’ agreement to acquire ArisGlobal extends beyond safety capability expansion. The strategic objective is to create a more connected Research & Development (R&D) environment in which clinical, safety, and real-world evidence continuously inform decisions across the therapy life cycle, rather than remain confined to siloed functional systems. …
  • See Us At
    July 21, 2026

    Join Sanket Anshuman, Practice Director at Everest Group, to explore how pharmacovigilance (PV) is evolving from a compliance-driven function to an AI-enabled, intelligence-led safety model. Discover how organizations can leverage AI, automation, and real-world data to…
  • Viewpoint
    June 29, 2026

    The post-approval phase represents one of the most complex and strategically critical stages in the life sciences product life cycle, requiring enterprises to ensure continuous safety monitoring, regulatory compliance, and real-world performance optimization. With increasing diverse…
  • Thematic Report
    May 04, 2026

    The global Clinical Research Organization (CRO) market is undergoing a transformation, shaped by rising clinical trial complexity, increasing regulatory requirements, and growing demand for faster, more efficient drug development. CROs continue to play a pivotal role…
  • Viewpoint
    April 28, 2026

    The global safety database market is at an inflection point, driven by increasing complexities in Pharmacovigilance (PV) operations, growing regulatory expectations, and rapid expansion of data sources such as real-world evidence, digital health tools, and patient-generated…
  • Market Insights™
    Nov. 05, 2025

  • Blog
    Nov. 02, 2025

    The clinical outsourcing market is undergoing a transition with the emergence of specialist-focused Clinical Research Organizations (CROs). A specialist CRO concentrates its expertise in a defined area, such as a therapeutic focus, trial phase or technology, or geographic niche, rather than offering broad,…
  • State of the Market
    Oct. 01, 2025

    The surge in case volumes, more stringent regulatory demands, and therapeutic areas’ rising complexities are significantly transforming pharmacovigilance (PV). As the industry adapts to more tailored reporting requirements and longer patient monitoring periods, enterprises are under…
  • Provider Compendium
    Sep. 30, 2025

    In recent years, life sciences enterprises have reoriented their R&D investments, prioritizing pipeline efficiency and a strategic focus on large and novel molecules. This shift has intensified efforts around cost containment and created a stronger need…
  • Provider Compendium
    Sep. 16, 2025

    Pharmacovigilance (PV) operations have become a strategic priority for life sciences enterprises facing heightened regulatory scrutiny, evolving safety standards, and growing complexity across global markets. This report provides an in-depth assessment of 12 leading PV service…
  • Aug. 29, 2025

    AWS View the full Peak Matrix report
  • Aug. 29, 2025

    AWS View the full Peak Matrix report
  • PEAK Matrix®
    Aug. 01, 2025

    The public cloud market has substantially grown in recent years, fueled by enterprises’ transformation and innovation needs. Amazon Web Services (AWS) has expanded its capabilities by investing in generative AI, industry-specific cloud solutions, data analytics, and…
  • Webinar Deck
    July 31, 2025

    Life sciences commercial teams are facing tighter budgets, faster launch cycles, and growing pressure to prove ROI from every investment and engagement. In this high-stakes environment, a new breed of specialist providers is stepping up, reshaping…
  • Event
    July 29, 2025

    Life sciences commercial teams are facing tighter budgets, faster launch cycles, and growing pressure to prove ROI from every investment and engagement. In this high-stakes environment, a new breed of specialist providers is stepping up, reshaping…
  • Provider Compendium
    July 29, 2025

    Enterprises are modernizing their technology foundations to stay agile, data-driven, and competitive. This shift is driving the demand for scalable, intelligent cloud platforms. Google Cloud has become a key enabler in this journey, offering advanced analytics,…
  • Provider Compendium
    July 29, 2025

    Over the past few years, the public cloud market has experienced significant growth due to the enterprise demand for business transformation, innovation, and resilience. Amazon Web Services (AWS) has accelerated its global adoption by investing in…
  • PEAK Matrix®
    July 16, 2025

    In recent years, life sciences enterprises have reprioritized and overhauled their R&D investments. They now focus on streamlining their pipelines and shifting toward new and large molecules. This transformation has compelled aggressive cost containment initiatives, prompting…
  • Provider Compendium
    July 07, 2025

    The public cloud market is significantly growing due to enterprises’ pursuit of digital transformation, innovation, and operational resilience. Microsoft Azure has effectively addressed this demand through strategic investments in generative AI (in collaboration with OpenAI), industry-tailored…
  • Viewpoint
    June 12, 2025

    Life sciences enterprises are increasingly turning to Real-world Evidence (RWE) as an essential input for decision-making across the product life cycle – from early-stage R&D to post-market access and safety. RWE offers validated insights into treatment…

Items per page